Viskase Holdings, Inc.

VISK ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Income Statement
Annual Quarterly

Income Statement

Line Item FY2024 FY2022 FY2021 FY2020 FY2019 FY2018 FY2017 FY2016
Revenue $26.0K $26.0K $701.0K $52.0K $207.0K $6.9M $8.4M $8.4M
Cost of Revenue — — — — — — — —
Gross Profit — — — — — — — —
Gross Margin — — — — — — — —
Operating Expenses
Research & Development — — — — — — — —
SG&A Expense — — — — — — — —
Operating Income $-1.3M $-1.0M $-469.0K $-1.3M $-973.0K $5.9M $7.0M $6.6M
Operating Margin -5,103.8% -3,969.2% -66.9% -2,509.6% -470.0% 84.6% 83.6% 79.3%
Interest Expense — — — — — — — —
Pretax Income $1.1M $-386.0K $-462.0K $-1.3M $-973.0K $5.9M $7.0M $6.6M
Income Tax Expense $347.0K $-200.0K $7.0K $7.0K $6.0K $6.0K $1.6M $7.8M
Net Income $778.0K $-186.0K $-469.0K $-1.3M $-979.0K $5.8M $5.4M $-1.1M
Net Margin 2,992.3% -715.4% -66.9% -2,521.2% -472.9% 84.5% 65.0% -13.4%
EPS (Basic) $-0.01 $-0.02 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
EPS (Diluted) $-0.01 $-0.02 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Shares Outstanding (Basic) 74.2M 74.2M 74.2M 51.1M 44.21B 44.21B 44.22B 44.22B
Shares Outstanding (Diluted) 74.2M 74.2M 74.2M 51.1M 44.21B 44.21B 44.22B 44.22B
Dividends Per Share — — — — — — — $0.00
← Newer Page 1 of 2 Older →